Table 2.
Base-case results
| Strategy | Cost in THB (US$) |
Life-years (LY) | QALYs loss | Incremental cost in THB (US$) |
Incremental LY | Incremental QALY loss | ICER per LY in THB (US$) | ICER per QALY saved in THB (US$) |
| 1 (PEP ID using PCEC) |
656 (18.6) |
15.77 | 0.1012 | Reference | ||||
| 2 (PEP ID using CPRV/PVRV) |
688 (19.5) |
15.77 | 0.1012 | Dominated | ||||
| 3 (PEP IM using CPRV/PVRV) |
746 (21.1) |
15.77 | 0.1370 | Dominated | ||||
| 4 (PEP IM using PCEC) |
758 (21.5) |
15.77 | 0.1370 | Dominated | ||||
| 5 (PrEP+PEP ID using PCEC) |
2033 (57.6) |
15.78 | 0.0676 | 1377 (39.0) |
0.0082 | 0.0336 | 167 638 (4748.9) |
40 977 (1160.8) |
| 6 (PrEP+PEP ID using CPRV/PVRV) |
2151 (60.9) |
15.78 | 0.0676 | Dominated | ||||
| 7 (PrEP+PEP IM using CPRV/PVRV) |
2595 (73.5) |
15.78 | 0.0676 | Dominated | ||||
| 8 (PrEP+PEP IM using PCEC) |
2648 (75.0) |
15.78 | 0.0676 | Dominated | ||||
CPRV, chromatographically purified Vero cell vaccine; ID, intradermal; IM, intramuscular; LY, life year; PCEC, purified chick embryo cell vaccine; PEP, Post exposure prophylaxis; PrEP, pre-exposure prophylaxis; PVRV, purified Vero cell rabies vaccine; QALY, quality-adjusted life year; THB, Thai Baht; US$, United States dollar.